Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-((3-((4-((5-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1h-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)(ethyl)amino)ethyl Dihydrogen Phosphate
2. Azd 1152
3. Azd-1152
4. Azd1152
1. Azd1152
2. 722543-31-9
3. Azd-1152
4. Barasertib [inn]
5. Azd 1152
6. 957881-03-7
7. Barasertib (who-dd)
8. 2-(ethyl(3-((4-((5-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1h-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)amino)ethyl Dihydrogen Phosphate
9. 16xc2u7w8n
10. Chembl415049
11. Barasertib [who-dd]
12. 2-(ethyl(3-(4-(5-(2-(3-fluorophenylamino)-2-oxoethyl)-1h-pyrazol-3-ylamino)quinazolin-7-yloxy)propyl)amino)ethyl Dihydrogen Phosphate
13. 5-[[7-[3-[ethyl[2-(phosphonooxy)ethyl]amino]propoxy]-4-quinazolinyl]amino]-n-(3-fluorophenyl)-1h-pyrazole-3-acetamide
14. 2-(ethyl(3-((4-((3-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1h-pyrazol-5-yl)amino)quinazolin-7-yl)oxy)propyl)amino)ethyl Dihydrogen Phosphate
15. 2-[ethyl-[3-[4-[[5-[2-(3-fluoroanilino)-2-oxoethyl]-1h-pyrazol-3-yl]amino]quinazolin-7-yl]oxypropyl]amino]ethyl Dihydrogen Phosphate
16. Azd1152 (barasertib)
17. Barasertibum
18. Unii-16xc2u7w8n
19. 2-{ethyl[3-({4-[(5-(2-[(3-fluorophenyl)amino]-2-oxoethyl}-1h-pyrazol-3-yl)amino]quinazolin-7-yl}oxy)propyl]amino}ethyl Dihydrogen Phosphate
20. Kinome_3324
21. 2-naphthylacrylate
22. Schembl613582
23. Gtpl7332
24. Schembl16671950
25. Dtxsid00222583
26. Chebi:167636
27. Bcpp000362
28. Hms3674c21
29. Hms3747e05
30. Bcp01734
31. Bcp13793
32. Cs-d0326
33. Ex-a3656
34. Azd1152-hqpa Dihydrogen Phosphate
35. Bdbm50241089
36. Nsc799355
37. Zinc43129461
38. Bcp9000360
39. Cs-0978
40. Cs-w000582
41. Db11747
42. Nsc-799355
43. Sb16659
44. Azd1152, 33
45. Ncgc00378734-03
46. Ac-35703
47. As-17018
48. Hy-10127
49. Db-074538
50. A9414
51. Ft-0662378
52. Ft-0736007
53. A15011
54. 543e319
55. 881a037
56. Q27074865
57. 1h-pyrazole-3-acetamide, 5-((7-(3-(ethyl(2- (phosphonooxy)ethyl)amino)propoxy)-4-quinazolinyl)amino)-n-(3-fluorophenyl)-
58. 1h-pyrazole-3-acetamide, 5-((7-(3-(ethyl(2-(phosphonooxy)ethyl)amino)propoxy)-4-quinazolinyl)amino)-n-(3-fluorophenyl)-
59. 1h-pyrazole-3-acetamide,5-[[7-[3-[ethyl[2-(phosphonooxy)ethyl]amino]propoxy]-4-quinazolinyl]amino]-n-(3-fluorophenyl)-
60. 2-[ethyl(3-{[4-({5-[2-(3-fluoroanilino)-2-oxoethyl]-1h-pyrazol-3-yl}amino)quinazolin-7-yl]oxy}propyl)amino]ethyl Dihydrogen Phosphate
61. 2-ethyl3-4-5-2-3-fluorophenylamino)-2-oxoethyl)-1h-pyrazol-3-ylamino)quinazolin-7-yloxy)propyl)amino)ethyl Dihydrogen Phosphate
62. N-(3-fluorophenyl)-3-[[7-[3-[ethyl[2-(phosphonooxy)ethyl]amino]propyloxy]quinazoline-4-yl]amino]-1h-pyrazole-5-acetamide
Molecular Weight | 587.5 g/mol |
---|---|
Molecular Formula | C26H31FN7O6P |
XLogP3 | -0.4 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 15 |
Exact Mass | 587.20574689 g/mol |
Monoisotopic Mass | 587.20574689 g/mol |
Topological Polar Surface Area | 175 Ų |
Heavy Atom Count | 41 |
Formal Charge | 0 |
Complexity | 859 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
30
PharmaCompass offers a list of Barasertib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Barasertib manufacturer or Barasertib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Barasertib manufacturer or Barasertib supplier.
PharmaCompass also assists you with knowing the Barasertib API Price utilized in the formulation of products. Barasertib API Price is not always fixed or binding as the Barasertib Price is obtained through a variety of data sources. The Barasertib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Barasertib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Barasertib, including repackagers and relabelers. The FDA regulates Barasertib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Barasertib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Barasertib supplier is an individual or a company that provides Barasertib active pharmaceutical ingredient (API) or Barasertib finished formulations upon request. The Barasertib suppliers may include Barasertib API manufacturers, exporters, distributors and traders.
Barasertib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Barasertib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Barasertib GMP manufacturer or Barasertib GMP API supplier for your needs.
A Barasertib CoA (Certificate of Analysis) is a formal document that attests to Barasertib's compliance with Barasertib specifications and serves as a tool for batch-level quality control.
Barasertib CoA mostly includes findings from lab analyses of a specific batch. For each Barasertib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Barasertib may be tested according to a variety of international standards, such as European Pharmacopoeia (Barasertib EP), Barasertib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Barasertib USP).